Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Share News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 42.00
Change: 0.30 (0.72%)
Spread: 1.00 (2.439%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 41.70
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Benchmark Holdings raises GBP21 million, eyes Oslo listing

Mon, 29th Nov 2021 15:06

(Alliance News) - Benchmark Holdings PLC said Monday it has raised GBP20.7 million in new equity to invest in its products, amid a strong outlook for the seafood industry that it serves.

The Sheffield, England-based aquaculture genetics, health and nutrition company said it placed 33.1 million new shares at 62.0 pence each to raise GBP20.5 million, while subscription to 295,000 shares by company directors at the same price added GBP200,000. Benchmark shares were trading down 0.6% at 62.10p on AIM in London on Monday afternoon.

Major shareholder Ferd AS, a Norwegian investment firm, took 12.3 million of the shares on offer, worth GBP7.6 million, and now has 185.4 million shares, a 26.3% stake.

Numis Corp PLC acted as nominated adviser, broker and bookrunner for the placing.

Benchmark said the fresh cash will be used to support the roll-out of its Ectosan Vet and CleanTreat sea-lice treatments.

Benchmark also has appointed Atle Eide as a non-executive director. Eide is chair of aquaculture firm Scale AQ and a member of the Norwegian Seafood Federation. Eide is former director of Kverva AS, a significant shareholder in Benchmark, so he will be considered a non-independent director.

Benchmark said it is considering a listing in Oslo and has appointed DnB Markets as well as Pareto Securities as advisers for this. The company noted that it has NOK850 million, about GBP70 million, in bonds maturing in June 2023, and that Oslo is the world's largest seafood-focused market.

Benchmark also Monday reported fourth quarter and annual results.

In the financial year that ended September 30, its pretax loss from continuing operations narrowed to GBP9.2 million from GBP22.6 million a year ago, as revenue rose by 18% to GBP125.1 million from GBP105.6 million. Total pretax loss narrowed to GBP11.6 million from GBP31.9 million.

In the fourth quarter alone, pretax loss from continuing operations widened to GBP3.2 million from GBP2.9 million, despite revenue rising by 48% to GBP37.3 million from GBP25.2 million. At the operating profit level, Benchmark swung to a profit of GBP500,000 from a loss of GBP2.8 million. Total pretax loss was GBP5.7 million, narrowed from GBP8.8 million.

Looking ahead, Benchmark said it currently is trading in line with expectations for the new financial year. It said salmon markets remain "solid" with a "positive outlook for continuous growth". Shrimp markets are showing recovery, the company said, while sea bass and sea bream market have recovered and are stable.

"The group delivered a strong financial performance across its three business areas reflecting our new commercial focus and supported by improving conditions, particularly in our important shrimp market which had been hardest hit by the pandemic," commented Chief Executive Officer Trond Williksen.

"There is good momentum in our business helped by positive conditions in our markets contributing to a good start to the new financial year across all business areas, consistent with our outlook for the year as a whole."

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2020 11:55

Benchmark Holdings Loss Narrows in Fourth Quarter On Revenue Growth

Benchmark Holdings Loss Narrows in Fourth Quarter On Revenue Growth

Read more
20 Nov 2020 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
18 Nov 2020 15:42

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO

Read more
10 Sep 2020 16:01

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

Read more
4 Sep 2020 18:04

UK DIRECTOR DEALINGS SUMMARY: Photo-Me Chief Executive Buys Shares

UK DIRECTOR DEALINGS SUMMARY: Photo-Me Chief Executive Buys Shares

Read more
4 Sep 2020 15:57

Director dealings: Benchmark CEO ups stake

(Sharecast News) - Benchmark Holdings said on Friday that chief executive Trond Williksen had acquired 180,000 ordinary shares in the AIM-listed veterinary services company.

Read more
28 Aug 2020 11:09

UK WINNERS & LOSERS SUMMARY: Amigo Rises 18% Amid Battle With Founder

UK WINNERS & LOSERS SUMMARY: Amigo Rises 18% Amid Battle With Founder

Read more
28 Aug 2020 10:42

Benchmark Holdings Loss Narrows In Third Quarter On Revenue Growth

Benchmark Holdings Loss Narrows In Third Quarter On Revenue Growth

Read more
28 Aug 2020 08:06

Benchmark losses widen YTD

(Sharecast News) - Veterinary services company Benchmark Holdings said on Friday that pre-tax losses had widened so far in 2020 as revenues slipped amid the Covid-19 pandemic.

Read more
21 Aug 2020 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Aug 2020 06:57

IN BRIEF: Benchmark Holdings Completes Sale Of Vaccine Facility

IN BRIEF: Benchmark Holdings Completes Sale Of Vaccine Facility

Read more
23 Jul 2020 20:20

IN BRIEF: Benchmark Holdings To Sell Vaccine Manufacturing Assets

IN BRIEF: Benchmark Holdings To Sell Vaccine Manufacturing Assets

Read more
1 Jul 2020 18:15

IN BRIEF: Benchmark Sells Non-Core Unit FVG For Up To GBP14.7 Million

IN BRIEF: Benchmark Sells Non-Core Unit FVG For Up To GBP14.7 Million

Read more
1 Jul 2020 13:26

Benchmark sells FishVet division to Zoetis subsidiary

(Sharecast News) - Aquaculture generics, health and nutrition company Benchmark Holdings has completed the sale of its wholly-owned subsidiary FVG, trading as 'FishVet', to Pharmaq, part of global animal health company Zoetis.

Read more
8 Jun 2020 13:38

DIRECTOR DEALINGS: Benchmark Holdings Directors Buys GBP272,000 Worth

DIRECTOR DEALINGS: Benchmark Holdings Directors Buys GBP272,000 Worth

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.